Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Chemical Biology & Drug Design
|
August 14, 2018
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
Lydia Pouga, Maria Mercedes Santoro, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 16, 2021
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease
Yagai Bouba, Daniele Armenia, Federica Forbici, et al.
International Journal of Antimicrobial Agents
|
July 4, 2026
Real world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir + rilpivirine
Greta Marchegiani, Francesco Paolo Antonucci, Ada Bertoli, et al.
AIDS Research and Human Retroviruses
|
February 3, 2009
Dynamics of NRTI resistance mutations during therapy interruption
Maria Trignetti, Tobias Sing, Valentina Svicher, et al.
AIDS Research and Therapy
|
May 14, 2020
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
Joseph Fokam, Armanda Nangmo, Carlson Wandum, et al.
The Journal of Antimicrobial Chemotherapy
|
May 21, 2013
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen
Claudia Alteri, Anna Artese, Gertjan Beheydt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 30, 2016
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
Mauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, et al.
Virus Genes
|
February 24, 2019
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice
Claudia Alteri, Rossana Scutari, Ada Bertoli, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
The Journal of Antimicrobial Chemotherapy
|
September 6, 2011
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
Claudia Alteri, Maria Mercedes Santoro, Isabella Abbate, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Chemical Biology & Drug Design
|
August 14, 2018
New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T)
Lydia Pouga, Maria Mercedes Santoro, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
September 16, 2021
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease
Yagai Bouba, Daniele Armenia, Federica Forbici, et al.
International Journal of Antimicrobial Agents
|
July 4, 2026
Real world evaluation of HIV-1 reservoir and resistance in virologically suppressed people after 52 weeks of treatment with long-acting cabotegravir + rilpivirine
Greta Marchegiani, Francesco Paolo Antonucci, Ada Bertoli, et al.
AIDS Research and Human Retroviruses
|
February 3, 2009
Dynamics of NRTI resistance mutations during therapy interruption
Maria Trignetti, Tobias Sing, Valentina Svicher, et al.
AIDS Research and Therapy
|
May 14, 2020
Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon
Joseph Fokam, Armanda Nangmo, Carlson Wandum, et al.
The Journal of Antimicrobial Chemotherapy
|
May 21, 2013
Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen
Claudia Alteri, Anna Artese, Gertjan Beheydt, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 30, 2016
Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA
Mauro Zaccarelli, Maria Mercedes Santoro, Daniele Armenia, et al.
Virus Genes
|
February 24, 2019
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice
Claudia Alteri, Rossana Scutari, Ada Bertoli, et al.
Antiviral Therapy
|
September 23, 2017
Viro-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia >500,000 copies/ml in clinical practice
Maria Mercedes Santoro, Domenico Di Carlo, Daniele Armenia, et al.
The Journal of Antimicrobial Chemotherapy
|
September 6, 2011
'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing
Claudia Alteri, Maria Mercedes Santoro, Isabella Abbate, et al.
Page
of 14